An aborted operation in La Jolla shows the true strength of an increasingly popular way to open blocked blood vessels. A Scripps Health cardiac team had planned to use a stent to clear a narrowed ...

Diagnosing coronary heart disease has been accomplished since the 1960s by coronary angiography. During the process, involving guiding a catheter tube through the body to the heart, contrast dye is ...

The ideal stent to treat very calcified lesions needs (1) a high radial force to resist the elastic recoil and radial crush and (2) a moderate outward expansive force to provide sufficient vessel ...

When it comes to stenting -- using metal tubes to prop open blocked arteries -- physicians are continuing to choose to gain entry to the circulatory system through an opening in the leg instead of the ...

Please provide your email address to receive an email when new articles are posted on . Since 2009, use of radial access has steadily grown at Morristown Medical Center in Morristown, N.J. With just 2 ...

Feb. 20 (UPI) --Researchers at Washington University in St. Louis have found same-day procedures to treat narrowing of the arteries in the heart using the arm can save millions of dollars. The study ...

ABBOTT PARK, Ill., Abbott today announced it received approval from the U.S. Food and Drug Administration (FDA) for XIENCE SierraTM, the newest generation of the company's gold-standard XIENCE ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. HINSDALE, Ill. — Smaller, sleeker, faster.

Please provide your email address to receive an email when new articles are posted on . Early results have indicated that a novel carotid artery stent featuring a double-layer design is safe and not ...

BOSTON, MA — A surgical revascularization strategy that uses multiple arterial coronary artery bypass grafts (MA-CABG) in patients with multivessel coronary artery disease results in lower mortality ...

NATICK, Mass., Boston Scientific Corporation today announced that it has completed enrollment in the ORION clinical trial, which is designed to evaluate the Company's EPIC™ Self-Expanding Nitinol ...